Local scientists and their colleagues from the CDC detail 2 cases of locally acquired dengue in November 2022 in Maricopa County.
Brazil's drug regulatory agency has approved Japan-based Takeda's 4-strain vaccine against dengue virus for use in people ages 4 to 60 years old.
The outbreak is unusual in its scale and seasonality.
The Maricopa County Department of Public Health (MCDPH) in Arizona this week reported a dengue infection in someone who was probably exposed to an infected mosquito in Maricopa County.
Mosquito surveillance has detected dengue virus in a mosquito trap in one of the county's neighborhood, the MCDPH said in a Nov 14 press release.
The prevalence of Clostridioides difficile infection (CDI) in the United States declined during the COVID-19 pandemic, but inpatient mortality and treatment costs were higher, according to a paper published yesterday in Open Forum Infectious Diseases.
A non-restrictive antibiotic stewardship intervention was associated with reduced fluoroquinolone prescribing at two community hospitals in Los Angeles, researchers reported yesterday in Open Forum Infectious Diseases.
An analysis of dental and pediatric primary care practices in Saudi Arabia found higher prescribing of broader-spectrum antibiotics and poor adherence to antibiotic prescribing guidelines, researchers reported yesterday in the American Journal of Infection Control.
Researchers updated a Commonwealth Fund study yesterday, and now estimate that COVID-19 vaccination has prevented 1.1 million US deaths and 10.3 million hospitalizations, up from July's figure of 279,000 deaths and 1.25 million hospitalizations prevented.
A modeling study yesterday suggests that the first human case of COVID-19 likely occurred in or around November 2019 in China, with the most likely date of origin being Nov 17. The study was published in PLOS Pathogens.
High doses of intravenous immunoglobulin (IVIG) in conjunction with an anticoagulant were associated with resolved vaccine-induced immune thrombotic thrombocytopenia (VITT) in three patients, according to a report yesterday in the New England Journal of Medicine.
VITT occurs when antibodies attack protein factor 4 (PF4), leading to blood clumping and clots.
